Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Ivor Douglas

Concepts (600)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial
23
2024
529
3.960
Why?
Sepsis
19
2024
509
2.890
Why?
Respiratory Insufficiency
12
2023
290
2.420
Why?
Fluid Therapy
11
2024
123
2.360
Why?
Critical Care
18
2024
476
2.310
Why?
Intensive Care Units
23
2024
617
2.230
Why?
Critical Illness
20
2024
646
2.180
Why?
Tracheostomy
5
2024
101
1.860
Why?
Shock, Septic
11
2024
186
1.680
Why?
Hospital Mortality
19
2024
776
1.610
Why?
Shock
3
2024
84
1.480
Why?
Hospitals
6
2023
581
1.350
Why?
Pneumonia
7
2023
568
1.230
Why?
Hypotension
4
2024
116
1.050
Why?
Resuscitation Orders
3
2023
45
1.050
Why?
Multiple Organ Failure
4
2024
146
0.990
Why?
Humans
132
2025
114709
0.950
Why?
Patient Readmission
6
2021
610
0.920
Why?
Vasoconstrictor Agents
5
2023
113
0.890
Why?
Middle Aged
55
2025
26738
0.890
Why?
Ultrasonography, Doppler
1
2024
105
0.870
Why?
Aged
42
2025
19074
0.860
Why?
Pneumonia, Ventilator-Associated
2
2015
40
0.840
Why?
Resuscitation
8
2024
252
0.790
Why?
Safety-net Providers
3
2023
95
0.790
Why?
Hemodynamics
3
2024
1012
0.780
Why?
Extracorporeal Membrane Oxygenation
2
2023
241
0.770
Why?
Severity of Illness Index
6
2021
2540
0.770
Why?
Hospitals, High-Volume
2
2019
39
0.770
Why?
Retrospective Studies
30
2024
12556
0.760
Why?
Patient Acceptance of Health Care
5
2021
681
0.740
Why?
Male
70
2025
55609
0.740
Why?
Monitoring, Physiologic
4
2024
249
0.740
Why?
Frailty
1
2023
115
0.730
Why?
Patient Positioning
1
2021
42
0.720
Why?
Diabetes Insipidus
1
2020
7
0.700
Why?
Practice Guidelines as Topic
6
2021
1395
0.690
Why?
Substance Withdrawal Syndrome
3
2021
159
0.650
Why?
Hospitals, Low-Volume
1
2019
22
0.640
Why?
Adult
43
2025
30554
0.630
Why?
Female
61
2025
59523
0.620
Why?
Dyspnea
2
2021
211
0.620
Why?
Diabetes Mellitus
2
2020
900
0.590
Why?
Alcoholism
5
2021
713
0.560
Why?
Ventilator-Induced Lung Injury
3
2018
49
0.550
Why?
California
5
2022
353
0.540
Why?
Neoplasms
3
2023
2097
0.540
Why?
Randomized Controlled Trials as Topic
11
2024
1214
0.540
Why?
Pulmonary Medicine
3
2015
87
0.520
Why?
Microbiological Techniques
1
2016
29
0.520
Why?
Sleep Medicine Specialty
1
2015
9
0.510
Why?
Acute Kidney Injury
7
2023
638
0.500
Why?
Acute Lung Injury
6
2023
299
0.490
Why?
Ethanol
2
2021
538
0.490
Why?
Molecular Diagnostic Techniques
1
2016
92
0.490
Why?
Health Policy
4
2024
334
0.490
Why?
Hyperemia
3
2024
45
0.480
Why?
Research Design
9
2023
928
0.470
Why?
Cohort Studies
11
2023
4895
0.460
Why?
Aged, 80 and over
12
2025
6347
0.450
Why?
Pulmonary Disease, Chronic Obstructive
7
2017
916
0.440
Why?
Renin-Angiotensin System
2
2025
72
0.440
Why?
Prone Position
3
2021
27
0.430
Why?
Bronchoalveolar Lavage Fluid
2
2016
590
0.430
Why?
Inpatients
3
2023
380
0.430
Why?
Receptor, EphA2
3
2018
19
0.430
Why?
Cause of Death
3
2015
361
0.420
Why?
Immune Tolerance
1
2015
323
0.420
Why?
Nicotinic Agonists
1
2014
100
0.410
Why?
Laryngoscopes
2
2023
38
0.410
Why?
Dual Specificity Phosphatase 1
1
2012
28
0.400
Why?
Cross Infection
5
2020
197
0.400
Why?
Noninvasive Ventilation
3
2017
32
0.400
Why?
Marijuana Smoking
1
2015
224
0.400
Why?
Lung
12
2018
3561
0.400
Why?
Apoptosis
6
2014
2363
0.390
Why?
Pulmonary Fibrosis
4
2017
323
0.390
Why?
Hospitalization
9
2025
1752
0.390
Why?
Immunity, Innate
1
2017
720
0.380
Why?
Tobacco Use Disorder
1
2014
234
0.380
Why?
Prospective Studies
12
2024
6220
0.380
Why?
Nicotine
1
2014
265
0.380
Why?
Lipopolysaccharides
4
2017
823
0.380
Why?
Organ Dysfunction Scores
2
2024
39
0.370
Why?
Drug Delivery Systems
1
2014
296
0.370
Why?
Child Development
1
2015
385
0.370
Why?
Protein C
5
2012
45
0.360
Why?
Tissue Plasminogen Activator
2
2024
225
0.360
Why?
Delirium
2
2024
66
0.360
Why?
Glycosaminoglycans
3
2016
79
0.360
Why?
Long-Term Care
2
2022
78
0.350
Why?
Emergency Service, Hospital
5
2024
1820
0.350
Why?
United States
18
2024
12186
0.340
Why?
Length of Stay
6
2024
962
0.340
Why?
Smoking Cessation
1
2014
374
0.340
Why?
Treatment Outcome
15
2024
9088
0.340
Why?
Antipsychotic Agents
2
2024
184
0.330
Why?
Public Health
1
2014
434
0.330
Why?
Comorbidity
4
2022
1448
0.330
Why?
Metabolic Syndrome
2
2023
321
0.330
Why?
Vena Cava, Inferior
3
2024
56
0.320
Why?
Cannabis
1
2015
384
0.320
Why?
Ephrin-A1
3
2018
4
0.320
Why?
Biomarkers
7
2023
3408
0.320
Why?
Intubation, Intratracheal
4
2024
216
0.310
Why?
Lipid A
2
2014
28
0.310
Why?
Societies, Medical
7
2021
664
0.310
Why?
Institutional Practice
1
2008
3
0.310
Why?
Anti-Bacterial Agents
1
2017
1481
0.300
Why?
Odds Ratio
6
2019
953
0.300
Why?
Personnel Staffing and Scheduling
1
2008
79
0.290
Why?
Pandemics
4
2024
1320
0.290
Why?
Betacoronavirus
2
2020
250
0.290
Why?
Neutrophils
3
2024
1176
0.290
Why?
Integrins
1
2007
79
0.280
Why?
Pulmonary Alveolar Proteinosis
1
2007
16
0.280
Why?
Neovascularization, Pathologic
2
2007
281
0.280
Why?
Renal Insufficiency, Chronic
2
2024
486
0.280
Why?
MAP Kinase Signaling System
2
2014
276
0.270
Why?
Lung Injury
3
2016
198
0.270
Why?
Patient Admission
2
2023
176
0.270
Why?
Ultrasonography
3
2024
634
0.270
Why?
Hyponatremia
1
2006
37
0.260
Why?
Double-Blind Method
9
2024
1660
0.260
Why?
Lung Diseases, Obstructive
1
2006
40
0.260
Why?
Leukocytes
1
2007
276
0.260
Why?
Medicaid
3
2021
407
0.250
Why?
Treatment Failure
7
2024
331
0.250
Why?
Biomedical Research
3
2021
585
0.250
Why?
Pneumonia, Viral
2
2020
338
0.250
Why?
Coronavirus Infections
2
2020
330
0.250
Why?
Laryngoscopy
2
2023
91
0.250
Why?
Academic Medical Centers
3
2021
411
0.250
Why?
Chemokines, CXC
1
2005
60
0.240
Why?
Bronchi
1
2006
232
0.240
Why?
Regeneration
1
2006
160
0.240
Why?
Bronchiectasis
1
2006
106
0.240
Why?
Oxazines
1
2024
25
0.240
Why?
Bronchiolitis Obliterans
1
2005
66
0.240
Why?
Succinylcholine
1
2024
7
0.240
Why?
Adrenal Insufficiency
2
2013
26
0.240
Why?
Infusions, Intravenous
5
2024
371
0.240
Why?
Methylprednisolone
1
2005
81
0.230
Why?
Hypoxia
3
2024
958
0.230
Why?
Respiratory Mucosa
1
2006
251
0.230
Why?
Venous Pressure
1
2024
8
0.230
Why?
Phagocytosis
1
2006
350
0.230
Why?
Patient Protection and Affordable Care Act
2
2016
99
0.230
Why?
Cytokines
7
2017
1841
0.230
Why?
Risk Factors
10
2021
8634
0.230
Why?
Morpholines
1
2024
102
0.230
Why?
Plasminogen
1
2024
33
0.230
Why?
Vasopressins
3
2021
56
0.230
Why?
Anti-Infective Agents
4
2012
225
0.220
Why?
Leukocyte Elastase
1
2024
80
0.220
Why?
Renal Dialysis
4
2023
374
0.220
Why?
beta Catenin
1
2005
219
0.220
Why?
Plasminogen Activator Inhibitor 1
1
2024
83
0.220
Why?
Atrial Pressure
1
2023
4
0.220
Why?
Receptor, Angiotensin, Type 1
1
2023
20
0.220
Why?
Diterpenes
2
2014
31
0.210
Why?
Craniocerebral Trauma
1
2005
134
0.210
Why?
Area Under Curve
3
2020
274
0.210
Why?
Lung Diseases
3
2016
701
0.210
Why?
Haloperidol
2
2024
35
0.210
Why?
Analgesics, Non-Narcotic
1
2024
120
0.210
Why?
Hemodynamic Monitoring
1
2022
1
0.210
Why?
Fibrosis
1
2005
453
0.210
Why?
Thiazoles
2
2024
110
0.210
Why?
Fibrinolysis
1
2024
158
0.200
Why?
Evidence-Based Medicine
5
2016
668
0.190
Why?
Clinical Decision-Making
1
2024
268
0.190
Why?
Early Diagnosis
4
2017
217
0.190
Why?
Transportation
1
2022
44
0.190
Why?
Acetaminophen
1
2024
241
0.190
Why?
Hydrocortisone
1
2003
267
0.190
Why?
Logistic Models
7
2017
1841
0.190
Why?
Pyridines
1
2024
425
0.190
Why?
Stroke Volume
1
2024
504
0.190
Why?
Vasodilator Agents
1
2023
302
0.190
Why?
Heart Arrest
2
2021
293
0.180
Why?
Receptors, Interleukin-6
1
2021
34
0.180
Why?
Central Nervous System Depressants
1
2021
81
0.180
Why?
Piperazines
2
2024
309
0.180
Why?
Internship and Residency
2
2019
926
0.180
Why?
Hospital Charges
1
2020
39
0.180
Why?
Animals
20
2018
31709
0.180
Why?
Community-Acquired Infections
3
2020
141
0.180
Why?
Reproducibility of Results
5
2024
2765
0.180
Why?
Rib Fractures
1
2020
25
0.180
Why?
Health Priorities
1
2020
34
0.180
Why?
Glucocorticoids
1
2005
532
0.180
Why?
Hydroxychloroquine
1
2020
54
0.180
Why?
Heart Failure
3
2023
1945
0.170
Why?
Cell Proliferation
2
2014
2187
0.170
Why?
Mice, Inbred C57BL
9
2018
4694
0.170
Why?
Antigens, Differentiation
1
2000
79
0.170
Why?
Patient Selection
1
2023
641
0.170
Why?
Patient Handoff
1
2019
26
0.170
Why?
Risk Adjustment
1
2020
76
0.160
Why?
Age Factors
4
2019
2894
0.160
Why?
Blood Glucose Self-Monitoring
1
2023
506
0.160
Why?
Cell Adhesion Molecules
1
2000
168
0.160
Why?
Hospital Costs
1
2019
104
0.160
Why?
Combined Modality Therapy
2
2020
1121
0.160
Why?
Dopamine Antagonists
1
2018
22
0.160
Why?
Health Services Accessibility
4
2020
763
0.160
Why?
ROC Curve
1
2020
442
0.150
Why?
Thrombosis
1
2021
298
0.150
Why?
Orthopedic Procedures
1
2020
208
0.150
Why?
Antimicrobial Stewardship
1
2020
94
0.150
Why?
Blood Glucose
2
2023
1829
0.150
Why?
Eosinophils
1
2000
278
0.150
Why?
Predictive Value of Tests
4
2016
1796
0.150
Why?
Optometry
1
2017
2
0.150
Why?
Mice
13
2017
14872
0.140
Why?
Guideline Adherence
2
2014
490
0.140
Why?
Platelet Count
2
2014
81
0.140
Why?
Tidal Volume
2
2014
75
0.140
Why?
Cell Adhesion
4
2012
432
0.140
Why?
Pyrimidines
2
2024
376
0.140
Why?
Lymphocyte Count
1
2017
133
0.140
Why?
Cystic Fibrosis
1
2006
955
0.140
Why?
Analysis of Variance
1
2020
1226
0.140
Why?
Transients and Migrants
1
2017
22
0.140
Why?
Attitude of Health Personnel
3
2019
975
0.140
Why?
Antibodies, Monoclonal, Humanized
1
2021
663
0.130
Why?
Delivery of Health Care
1
2023
833
0.130
Why?
Tretinoin
1
2017
122
0.130
Why?
Clinical Trials as Topic
1
2021
932
0.130
Why?
Burnout, Professional
1
2021
322
0.130
Why?
Nephrectomy
2
2008
150
0.130
Why?
Ventricular Function, Right
1
2018
250
0.130
Why?
Continuity of Patient Care
1
2018
253
0.130
Why?
Health Insurance Exchanges
1
2016
2
0.130
Why?
Sleep Wake Disorders
2
2017
233
0.130
Why?
Risk Management
1
2017
89
0.130
Why?
Breath Tests
1
2016
82
0.130
Why?
Ventricular Dysfunction, Right
1
2018
217
0.130
Why?
Staphylococcus aureus
2
2011
389
0.130
Why?
Respiratory Tract Diseases
1
2017
138
0.120
Why?
Prognosis
5
2021
3330
0.120
Why?
Quality of Life
2
2024
2353
0.120
Why?
Research
1
2018
394
0.120
Why?
Patient Care Team
1
2019
517
0.120
Why?
Survival Analysis
4
2014
1211
0.120
Why?
Marriage
1
2016
106
0.120
Why?
Alcohol Withdrawal Seizures
1
2014
1
0.120
Why?
Risk Assessment
5
2015
2968
0.120
Why?
Bronchoalveolar Lavage
1
2015
84
0.120
Why?
Alcohol Withdrawal Delirium
1
2014
8
0.120
Why?
Automation
1
2015
74
0.120
Why?
Multicenter Studies as Topic
3
2023
249
0.120
Why?
Bacteriological Techniques
1
2015
65
0.120
Why?
Physicians
2
2021
772
0.120
Why?
5-Lipoxygenase-Activating Protein Inhibitors
1
2014
1
0.120
Why?
5-Lipoxygenase-Activating Proteins
1
2014
5
0.120
Why?
Education, Medical
1
2017
215
0.120
Why?
Catheterization, Central Venous
1
2015
83
0.120
Why?
Fluorobenzenes
1
2014
11
0.120
Why?
Leukotrienes
1
2014
35
0.120
Why?
Phenanthrenes
1
2014
10
0.120
Why?
Poverty
2
2016
442
0.110
Why?
APACHE
2
2011
58
0.110
Why?
CD4-Positive T-Lymphocytes
1
2000
959
0.110
Why?
Down-Regulation
2
2017
594
0.110
Why?
Potassium
1
2014
128
0.110
Why?
Alanine Transaminase
1
2014
142
0.110
Why?
Systemic Inflammatory Response Syndrome
1
2014
72
0.110
Why?
Microscopy
1
2015
125
0.110
Why?
Kaplan-Meier Estimate
5
2018
811
0.110
Why?
Angiotensin II
2
2025
87
0.110
Why?
Laryngeal Masks
1
2013
13
0.110
Why?
Quinolines
1
2014
129
0.110
Why?
Time Factors
7
2023
6116
0.100
Why?
Health Knowledge, Attitudes, Practice
2
2024
1183
0.100
Why?
Patient Discharge
1
2018
773
0.100
Why?
Sensitivity and Specificity
2
2015
1694
0.100
Why?
Cisplatin
1
2014
262
0.100
Why?
Physician-Patient Relations
1
2017
462
0.100
Why?
Glycocalyx
1
2012
18
0.100
Why?
Patient-Centered Care
1
2017
473
0.100
Why?
Acute Disease
3
2016
911
0.100
Why?
Oxygen
3
2023
854
0.100
Why?
Follow-Up Studies
5
2024
4411
0.100
Why?
Supine Position
1
2012
32
0.100
Why?
Indoles
1
2014
304
0.100
Why?
Insurance, Health
1
2014
244
0.100
Why?
Biomarkers, Pharmacological
1
2012
26
0.100
Why?
Data Interpretation, Statistical
2
2011
321
0.100
Why?
I-kappa B Proteins
1
2012
79
0.100
Why?
Health Status
1
2017
722
0.100
Why?
Clinical Alarms
1
2011
10
0.100
Why?
Data Display
1
2011
19
0.100
Why?
Endotoxemia
1
2012
86
0.090
Why?
Adrenergic beta-2 Receptor Agonists
1
2011
32
0.090
Why?
Albuterol
1
2011
102
0.090
Why?
Genetic Markers
1
2012
320
0.090
Why?
Sulfonamides
1
2014
445
0.090
Why?
Fibrinolytic Agents
2
2024
234
0.090
Why?
Decision Making
1
2017
782
0.090
Why?
Interferons
1
2011
151
0.090
Why?
Peroxidase
2
2008
163
0.090
Why?
Alcohol-Related Disorders
1
2011
113
0.090
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
373
0.090
Why?
Recombinant Proteins
5
2012
1230
0.090
Why?
Survival Rate
3
2015
1644
0.090
Why?
Stenotrophomonas maltophilia
1
2009
2
0.090
Why?
Disease Models, Animal
5
2018
3535
0.090
Why?
Clinical Protocols
2
2012
233
0.080
Why?
Thoracic Diseases
1
2009
13
0.080
Why?
Databases, Factual
2
2016
1125
0.080
Why?
Cell Movement
3
2011
869
0.080
Why?
Ligands
2
2023
562
0.080
Why?
Adrenal Cortex Hormones
1
2013
497
0.080
Why?
Gram-Negative Bacterial Infections
1
2009
37
0.080
Why?
Symptom Assessment
2
2020
119
0.080
Why?
Blotting, Western
1
2012
1147
0.080
Why?
Polymerase Chain Reaction
1
2012
993
0.080
Why?
Cues
1
2011
300
0.080
Why?
Up-Regulation
1
2012
808
0.080
Why?
Confidence Intervals
1
2010
305
0.080
Why?
Age Distribution
1
2010
342
0.080
Why?
Wounds and Injuries
1
2016
749
0.080
Why?
Sex Distribution
1
2010
337
0.080
Why?
Pancreatitis
1
2009
107
0.080
Why?
Healthcare Disparities
1
2014
480
0.080
Why?
Pneumonia, Bacterial
1
2009
106
0.080
Why?
Pulmonary Alveoli
2
2012
373
0.080
Why?
Incidence
1
2014
2313
0.080
Why?
Models, Statistical
1
2012
599
0.080
Why?
Work Schedule Tolerance
1
2008
35
0.080
Why?
Clinical Trials, Phase III as Topic
2
2023
82
0.070
Why?
Child, Preschool
2
2015
9119
0.070
Why?
United Kingdom
1
2008
226
0.070
Why?
Disease Progression
4
2017
2381
0.070
Why?
Clinical Competence
1
2014
893
0.070
Why?
Interleukin-6
2
2008
676
0.070
Why?
Signal Transduction
4
2018
4516
0.070
Why?
Rats, Sprague-Dawley
1
2012
2218
0.070
Why?
Workload
1
2008
132
0.070
Why?
Flavonoids
1
2007
66
0.070
Why?
Carcinoma, Non-Small-Cell Lung
1
1995
961
0.070
Why?
Mandatory Programs
1
2007
15
0.070
Why?
Pulmonary Emphysema
2
2007
272
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2024
797
0.070
Why?
Adolescent
5
2025
17855
0.070
Why?
Demeclocycline
1
2006
3
0.070
Why?
Mice, Inbred C3H
1
2007
239
0.070
Why?
Young Adult
5
2025
10472
0.070
Why?
Methicillin Resistance
1
2006
18
0.070
Why?
Lithium Compounds
1
2006
9
0.070
Why?
Sex Factors
3
2018
1715
0.070
Why?
Mitogen-Activated Protein Kinase 3
1
2007
146
0.070
Why?
Mitogen-Activated Protein Kinase 1
1
2007
164
0.070
Why?
Rats
2
2012
4958
0.070
Why?
Diuretics
1
2006
66
0.070
Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2006
97
0.070
Why?
Hospitals, Urban
2
2018
127
0.070
Why?
Mesoderm
1
2007
138
0.070
Why?
Protein Kinase Inhibitors
2
2024
785
0.070
Why?
Hospital Information Systems
1
2006
13
0.070
Why?
History, 20th Century
2
2017
264
0.070
Why?
Hypertension, Pulmonary
2
2007
1729
0.070
Why?
Intercellular Adhesion Molecule-1
2
2012
154
0.060
Why?
Mice, Inbred BALB C
2
2005
1144
0.060
Why?
Radiography, Thoracic
1
2007
150
0.060
Why?
Occupational Health
1
2008
165
0.060
Why?
Heparin
1
2007
224
0.060
Why?
Butylated Hydroxytoluene
1
2005
31
0.060
Why?
Asparagine
1
2005
29
0.060
Why?
Vocabulary
1
2006
41
0.060
Why?
Gene Expression Profiling
1
2012
1518
0.060
Why?
Gene Expression Regulation
2
2012
2320
0.060
Why?
Cyclin D1
1
2005
61
0.060
Why?
Emphysema
1
2006
107
0.060
Why?
Venous Thrombosis
1
2007
140
0.060
Why?
Cell Line, Transformed
1
2005
133
0.060
Why?
Medical Order Entry Systems
1
2006
41
0.060
Why?
Blood Vessels
1
2007
180
0.060
Why?
Caspase Inhibitors
1
2005
78
0.060
Why?
Macrophages
2
2014
1263
0.060
Why?
Angiotensin I
1
2025
5
0.060
Why?
Ischemia
1
2008
362
0.060
Why?
Bronchoscopy
1
2007
245
0.060
Why?
Necrosis
1
2005
211
0.060
Why?
Androstanols
1
2024
5
0.060
Why?
Neuromuscular Depolarizing Agents
1
2024
5
0.060
Why?
Neuromuscular Nondepolarizing Agents
1
2024
8
0.060
Why?
Colorado
4
2017
4100
0.060
Why?
HMGB1 Protein
1
2005
48
0.060
Why?
Diabetic Ketoacidosis
1
2007
160
0.060
Why?
Hope
1
2024
13
0.060
Why?
Neuromuscular Blocking Agents
1
2024
24
0.060
Why?
Pyridazines
1
2024
46
0.060
Why?
Caspases
1
2005
245
0.060
Why?
Cadherins
1
2005
175
0.060
Why?
Practice Patterns, Physicians'
3
2024
1177
0.060
Why?
T-Lymphocyte Subsets
1
2006
383
0.060
Why?
Renal Replacement Therapy
1
2024
66
0.060
Why?
Mental Health
2
2022
562
0.060
Why?
Medicago
1
2023
1
0.060
Why?
Steroids
2
2021
144
0.060
Why?
Uncertainty
1
2024
95
0.060
Why?
Pleural Effusion
1
2024
47
0.060
Why?
Enzyme Inhibitors
1
2007
750
0.060
Why?
Atrial Function, Right
1
2023
12
0.050
Why?
Angiotensins
1
2023
10
0.050
Why?
Inflammatory Bowel Diseases
1
2007
284
0.050
Why?
Autoimmune Diseases
1
2006
382
0.050
Why?
Collagen
1
2005
415
0.050
Why?
Antineoplastic Agents
1
2014
1879
0.050
Why?
Multivariate Analysis
2
2017
1430
0.050
Why?
Heparitin Sulfate
2
2014
39
0.050
Why?
Biopsy
1
2007
1036
0.050
Why?
Drug Administration Schedule
2
2018
718
0.050
Why?
Decision Support Techniques
2
2020
355
0.050
Why?
Anticoagulants
1
2007
550
0.050
Why?
Homeostasis
1
2006
573
0.050
Why?
Child
2
2015
18422
0.050
Why?
Diagnosis, Differential
1
2007
1342
0.050
Why?
Lung Neoplasms
1
1995
2177
0.050
Why?
Video Recording
1
2023
143
0.050
Why?
Staphylococcal Infections
1
2006
340
0.050
Why?
Hemoglobins
1
2024
315
0.050
Why?
Infant
1
2015
7964
0.050
Why?
Creatinine
2
2015
425
0.050
Why?
Endothelial Cells
1
2007
687
0.050
Why?
p38 Mitogen-Activated Protein Kinases
2
2014
260
0.050
Why?
Partial Thromboplastin Time
1
2021
51
0.050
Why?
Lung Diseases, Interstitial
1
2007
508
0.050
Why?
Oligopeptides
1
2023
236
0.050
Why?
Perioperative Care
1
2022
127
0.050
Why?
Electrocardiography
1
2024
560
0.050
Why?
Peptide Fragments
1
2025
666
0.050
Why?
Antibodies
2
2018
371
0.050
Why?
Hemorrhage
1
2005
620
0.040
Why?
Chronic Disease
1
2006
1578
0.040
Why?
Leukotriene C4
1
2000
12
0.040
Why?
CD18 Antigens
1
2000
33
0.040
Why?
N-Formylmethionine Leucyl-Phenylalanine
1
2000
65
0.040
Why?
Glasgow Coma Scale
1
2020
153
0.040
Why?
CD11 Antigens
1
2000
30
0.040
Why?
Drug Resistance, Microbial
1
2020
66
0.040
Why?
Costs and Cost Analysis
1
2020
196
0.040
Why?
Epithelial Cells
1
2005
951
0.040
Why?
Surveys and Questionnaires
3
2021
4624
0.040
Why?
Needs Assessment
1
2021
314
0.040
Why?
Oxidative Stress
1
2005
1076
0.040
Why?
Smoking
1
2006
1383
0.040
Why?
Flow Cytometry
2
2017
1083
0.040
Why?
Algorithms
1
2006
1470
0.040
Why?
Aftercare
1
2001
186
0.040
Why?
Hospitals, University
1
2019
172
0.040
Why?
NF-kappa B
2
2018
641
0.040
Why?
T-Lymphocytes
1
2006
1737
0.040
Why?
Mice, Knockout
3
2012
2570
0.040
Why?
Infection Control
1
2020
135
0.040
Why?
Adjuvants, Immunologic
1
2000
206
0.040
Why?
Injury Severity Score
1
2020
499
0.040
Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2018
2
0.040
Why?
Linear Models
1
2020
768
0.040
Why?
Trauma Centers
1
2020
362
0.040
Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2018
36
0.040
Why?
Family
1
2022
589
0.040
Why?
Mortality
1
2019
287
0.040
Why?
Victoria
1
2017
15
0.040
Why?
Antigens, CD
1
2000
442
0.040
Why?
History, 17th Century
1
2017
15
0.040
Why?
History, 16th Century
1
2017
14
0.040
Why?
History, 15th Century
1
2017
11
0.040
Why?
Recovery of Function
1
2021
574
0.040
Why?
Cross-Sectional Studies
2
2021
4410
0.040
Why?
History, Ancient
1
2017
48
0.040
Why?
United Arab Emirates
1
2017
5
0.040
Why?
History, Medieval
1
2017
40
0.030
Why?
Drug Therapy, Combination
2
2012
951
0.030
Why?
Critical Care Outcomes
1
2016
12
0.030
Why?
History, 21st Century
1
2017
159
0.030
Why?
Refugees
1
2017
54
0.030
Why?
Probability
1
2017
289
0.030
Why?
Lymphocyte Activation
1
2000
1037
0.030
Why?
Trauma Severity Indices
1
2016
114
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2018
398
0.030
Why?
Anxiety
1
2022
840
0.030
Why?
Pilot Projects
1
2019
1373
0.030
Why?
Uteroglobin
1
2014
16
0.030
Why?
Socioeconomic Factors
1
2018
1079
0.030
Why?
Cost-Benefit Analysis
1
2017
544
0.030
Why?
Chemokine CXCL2
1
2014
41
0.030
Why?
Arachidonate 5-Lipoxygenase
1
2014
45
0.030
Why?
Rosuvastatin Calcium
1
2014
17
0.030
Why?
Nitrates
1
2014
72
0.030
Why?
MAP Kinase Kinase 4
1
2014
23
0.030
Why?
Nitrites
1
2014
75
0.030
Why?
Risk
1
2017
812
0.030
Why?
Creatine Kinase
1
2014
75
0.030
Why?
Quality Indicators, Health Care
1
2017
287
0.030
Why?
Epoxy Compounds
1
2014
31
0.030
Why?
Quality Improvement
1
2021
950
0.030
Why?
Chondroitin Sulfates
1
2014
33
0.030
Why?
Liver Failure
1
2014
75
0.030
Why?
Leukocyte Count
1
2014
293
0.030
Why?
Toll-Like Receptor 2
1
2014
110
0.030
Why?
Kidney Function Tests
1
2014
140
0.030
Why?
Depression
1
2022
1134
0.030
Why?
Manikins
1
2013
24
0.030
Why?
Chromatography, Liquid
1
2015
347
0.030
Why?
Bronchial Spasm
1
2013
4
0.030
Why?
Cryptogenic Organizing Pneumonia
1
2013
17
0.030
Why?
Mass Spectrometry
1
2016
633
0.030
Why?
Contraindications
1
2013
85
0.030
Why?
Anesthesiology
1
2013
35
0.030
Why?
Tandem Mass Spectrometry
1
2015
412
0.030
Why?
Protein C Deficiency
1
2012
2
0.030
Why?
Connective Tissue Diseases
1
2013
71
0.030
Why?
Glucuronidase
1
2012
42
0.030
Why?
Cells, Cultured
1
2000
3886
0.030
Why?
Knowledge Bases
1
2012
17
0.030
Why?
Renal Insufficiency
1
2014
137
0.030
Why?
Intestinal Perforation
1
2012
39
0.030
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2012
73
0.020
Why?
Quality of Health Care
1
2017
573
0.020
Why?
Triage
1
2014
199
0.020
Why?
Disease Management
1
2016
560
0.020
Why?
Water-Electrolyte Balance
1
2011
26
0.020
Why?
Adoptive Transfer
1
2012
195
0.020
Why?
Endothelium
1
2012
111
0.020
Why?
Quality Assurance, Health Care
1
2014
311
0.020
Why?
Toll-Like Receptor 4
1
2014
287
0.020
Why?
Cross-Over Studies
1
2013
440
0.020
Why?
Epistasis, Genetic
1
2012
67
0.020
Why?
General Surgery
1
2013
127
0.020
Why?
Cell Survival
1
2014
1021
0.020
Why?
Internal Medicine
1
2013
211
0.020
Why?
Longitudinal Studies
1
2017
2387
0.020
Why?
Microbial Viability
1
2011
79
0.020
Why?
Arthroplasty, Replacement, Knee
1
2014
246
0.020
Why?
Superoxides
1
2011
214
0.020
Why?
Enzyme Activation
1
2012
785
0.020
Why?
Interleukin-8
1
2011
237
0.020
Why?
Viruses
1
2011
94
0.020
Why?
Cell Separation
1
2011
291
0.020
Why?
Single-Payer System
1
2009
2
0.020
Why?
Survivors
1
2013
411
0.020
Why?
Species Specificity
1
2011
542
0.020
Why?
Disease-Free Survival
1
2011
620
0.020
Why?
Cell Death
1
2011
323
0.020
Why?
Administration, Inhalation
1
2011
641
0.020
Why?
Case-Control Studies
1
2016
3004
0.020
Why?
Nitric Oxide
1
2014
823
0.020
Why?
Information Dissemination
1
2011
186
0.020
Why?
Self Report
1
2013
696
0.020
Why?
Advisory Committees
1
2010
208
0.020
Why?
Drug Resistance, Bacterial
1
2009
155
0.020
Why?
Cell Line
1
2014
2637
0.020
Why?
Precision Medicine
1
2012
337
0.020
Why?
Microbial Sensitivity Tests
1
2009
300
0.020
Why?
Total Quality Management
1
2008
61
0.020
Why?
Ventilator Weaning
1
2008
33
0.020
Why?
Placebos
1
2008
197
0.020
Why?
Neutrophil Infiltration
1
2008
96
0.020
Why?
Capillary Permeability
1
2008
139
0.020
Why?
United States Food and Drug Administration
1
2008
172
0.020
Why?
Health Plan Implementation
1
2008
132
0.020
Why?
Interdisciplinary Communication
1
2008
183
0.020
Why?
Drug Industry
1
2008
103
0.020
Why?
Tumor Necrosis Factor-alpha
1
2012
1140
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1842
0.020
Why?
Chemokines
1
2008
216
0.020
Why?
Acid-Base Equilibrium
1
2007
29
0.020
Why?
Umbilical Veins
1
2006
58
0.020
Why?
Cost Control
1
2006
39
0.020
Why?
CD8 Antigens
1
2006
69
0.020
Why?
Ketones
1
2007
44
0.020
Why?
Medical Audit
1
2007
75
0.020
Why?
Microcirculation
1
2007
135
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2006
103
0.020
Why?
Bacillus subtilis
1
2006
58
0.020
Why?
CD4 Antigens
1
2006
123
0.020
Why?
Information Management
1
2006
15
0.020
Why?
Cell Count
1
2006
303
0.020
Why?
Fluorescent Antibody Technique
1
2006
397
0.020
Why?
Genome-Wide Association Study
1
2012
1177
0.020
Why?
User-Computer Interface
1
2006
140
0.020
Why?
Interleukin-10
1
2006
299
0.010
Why?
Polymorphism, Single Nucleotide
1
2012
1880
0.010
Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
238
0.010
Why?
Asthma
1
2017
2029
0.010
Why?
Inflammation Mediators
1
2006
477
0.010
Why?
Hypoglycemia
1
2007
387
0.010
Why?
Endothelium, Vascular
1
2007
847
0.010
Why?
Cardiotonic Agents
1
2001
119
0.010
Why?
Hypothermia, Induced
1
2001
66
0.010
Why?
Mass Screening
1
2006
1006
0.010
Why?
RNA, Messenger
1
2006
2553
0.010
Why?
Hypoglycemic Agents
1
2007
1013
0.010
Why?
Dopamine
1
2001
236
0.010
Why?
Anti-Inflammatory Agents
1
2001
447
0.010
Why?
Insulin
1
2007
2080
0.010
Why?
Douglas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)